0000950170-24-048467.txt : 20240425
0000950170-24-048467.hdr.sgml : 20240425
20240425170834
ACCESSION NUMBER: 0000950170-24-048467
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240424
FILED AS OF DATE: 20240425
DATE AS OF CHANGE: 20240425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mates Sharon
CENTRAL INDEX KEY: 0001585699
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 24877398
MAIL ADDRESS:
STREET 1: C/O INTRA-CELLULAR THERAPIES, INC.
STREET 2: 3960 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10032
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
4
1
ownership.xml
4
X0508
4
2024-04-24
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001585699
Mates Sharon
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK
NY
10016
true
true
false
false
Chairman and CEO
false
Common Stock
2024-04-24
4
M
false
8638
16.86
A
1058947
D
Common Stock
2024-04-24
4
M
false
11382
17.57
A
1070329
D
Stock Option (right to buy)
16.86
2024-04-24
4
M
false
8638
0
D
2024-06-30
Common Stock
8638
0
D
Stock Option (right to buy)
17.57
2024-04-24
4
M
false
11382
0
D
2025-01-02
Common Stock
11382
216998
D
This option was granted on June 30, 2014 with an exercise price of $16.86 per share and will expire on June 30, 2024. All shares underlying this option have vested.
This option was granted on January 2, 2015 with an exercise price of $17.57 per share and will expire on January 2, 2025. All shares underlying this option have vested.
/s/ Lawrence J. Hineline, Attorney-in-fact
2024-04-25